| Fiscal period | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Period End Date | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 |
|---|
| Sales | 11,673.00 | 11,362.00 | 11,099.00 | 10,584.00 | 10,163.00 | 9,968.00 | 10,719.00 | 9,413.00 | 13,936.00 | 13,893.00 |
| Total Revenues | 11,673.00 | 11,362.00 | 11,099.00 | 10,584.00 | 10,163.00 | 9,968.00 | 10,719.00 | 9,413.00 | 13,936.00 | 13,893.00 |
| Cost of goods sold | 7,086.00 | 6,601.00 | 6,340.00 | 6,110.00 | 6,047.00 | 5,822.00 | 6,138.00 | 5,251.00 | 6,802.00 | 6,847.00 |
| Gross Profit | 4,587.00 | 4,761.00 | 4,759.00 | 4,474.00 | 4,116.00 | 4,146.00 | 4,581.00 | 4,162.00 | 7,134.00 | 7,046.00 |
| Goodwill amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research and development expenses | 521.00 | 595.00 | 654.00 | 615.00 | 646.00 | 603.00 | 610.00 | 582.00 | 1,081.00 | 946.00 |
| In-process research and development expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Marketing and administrative expenses | 2,469.00 | 2,535.00 | 2,620.00 | 2,627.00 | 2,725.00 | 3,094.00 | 3,315.00 | 3,084.00 | 3,283.00 | 3,154.00 |
| Other operating income | 19.00 | 141.00 | 99.00 | 56.00 | 0.00 | -- | -- | -- | -- | -- |
| Operating income | 1,616.00 | 1,772.00 | 1,584.00 | 1,288.00 | 745.00 | 449.00 | 656.00 | 496.00 | -- | -- |
| Net interest expense | 134.00 | 71.00 | 45.00 | 55.00 | 66.00 | 126.00 | 145.00 | 128.00 | 87.00 | 54.00 |
| Restructuring charges, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other income (expense) net | (190.00) | (731.00) | 78.00 | (133.00) | 4,275.00 | 105.00 | (21.00) | 7.00 | 155.00 | (83.00) |
| Other special charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Charge relating to A, AF and AX series dialyzers | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (loss) before income taxes | 1,292.00 | 970.00 | 1,617.00 | 1,100.00 | 4,954.00 | 428.00 | 490.00 | 375.00 | 2,838.00 | 2,809.00 |
| Income tax expense (benefit) | 182.00 | (41.00) | 65.00 | 491.00 | (12.00) | 35.00 | 33.00 | 60.00 | 555.00 | 553.00 |
| Current: Federal | 7.00 | 8.00 | 21.00 | -- | 10.00 | (251.00) | (305.00) | -- | 122.00 | 75.00 |
| Current State and local | (7.00) | 3.00 | (1.00) | -- | (3.00) | (6.00) | (44.00) | -- | 55.00 | 32.00 |
| Current International | 270.00 | 258.00 | 308.00 | -- | 282.00 | 345.00 | 398.00 | -- | 395.00 | 274.00 |
| Deferred: Federal | (99.00) | (140.00) | (228.00) | -- | (286.00) | (9.00) | 63.00 | -- | 112.00 | 155.00 |
| Deferred State and local | 5.00 | (29.00) | 0.00 | -- | 3.00 | (20.00) | 7.00 | -- | (81.00) | (6.00) |
| Deferred International | 6.00 | (141.00) | (35.00) | -- | (18.00) | (24.00) | (86.00) | -- | (48.00) | 23.00 |
| Income from Continuing Operations | 1,110.00 | 1,011.00 | 1,552.00 | 609.00 | 4,966.00 | 393.00 | 457.00 | 315.00 | 2,283.00 | -- |
| Income (loss) from discontinued operations | -- | -- | (6.00) | (7.00) | (1.00) | 575.00 | 2,040.00 | 1,697.00 | 43.00 | -- |
| Income from continuing operations before cumulative effect of accounting changes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of accounting changes, net of income tax benefit | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income(Loss) before Preferred Dividend & Noncontrolling Interest | 1,110.00 | 1,011.00 | 1,546.00 | 602.00 | -- | -- | -- | -- | -- | 2,256.00 |
| Less- Net income attributable to noncontrolling interests | 8.00 | 10.00 | -- | -- | -- | -- | -- | -- | -- | 32.00 |
| Net income (loss) attributable to common stockholders | 1,102.00 | 1,001.00 | 1,546.00 | 602.00 | 4,965.00 | 968.00 | 2,497.00 | 2,012.00 | 2,326.00 | 2,224.00 |
| Earnings per basic common share Continuing operations | 2.17 | 1.97 | 2.91 | 1.12 | 9.10 | 0.72 | 0.84 | 0.58 | 4.14 | -- |
| Earnings per basic common share Discontinued operations | -- | -- | (0.01) | (0.01) | (0.01) | 1.06 | 3.77 | 3.12 | 0.08 | -- |
| Cumulative effect of accounting changes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | 2.17 | 1.97 | 2.90 | 1.11 | 9.09 | 1.78 | 4.61 | 3.70 | 4.22 | 3.91 |
| Earnings per diluted common share Continuing operations | 2.13 | 1.93 | 2.84 | 1.10 | 9.01 | 0.72 | 0.83 | 0.57 | 4.11 | -- |
| Continuing operations, before cumulative effect of accounting changes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings per diluted common share Discontinued operations | -- | -- | (0.01) | (0.02) | -- | 1.04 | 3.73 | 3.09 | 0.07 | -- |
| Cumulative effect of accounting changes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | 2.13 | 1.93 | 2.83 | 1.08 | 9.01 | 1.76 | 4.56 | 3.66 | 4.18 | 3.88 |
| Weighted Average Shares Outstanding (Basic) | 509.00 | 509.00 | 534.00 | 543.00 | 546.00 | 545.00 | 542.00 | 543.00 | 551.00 | 569.00 |
| Weighted Average Shares Outstanding (Diluted) | 517.00 | 519.00 | 546.00 | 555.00 | 551.00 | 549.00 | 547.00 | 549.00 | 556.00 | 573.00 |